Death-associated protein kinase 2 (DAPK2) is a CaM-regulated Ser/Thr protein kinase, involved in apoptosis, autophagy, granulocyte differentiation and motility regulation, whose activity is controlled by autoinhibition, autophosphorylation, dimerization and interaction with scaffolding proteins 14-3-3. However, the structural basis of 14-3-3-mediated DAPK2 regulation remains unclear. Here, we structurally and biochemically characterize the full-length human DAPK2:14-3-3 complex by combining several biophysical techniques. The results from our X-ray crystallographic analysis revealed that Thr369 phosphorylation at the DAPK2 C terminus creates a high-affinity canonical mode III 14-3-3-binding motif, further enhanced by the diterpene glycoside Fusicoccin A. Moreover, concentration-dependent DAPK2 dimerization is disrupted by Ca2+/CaM binding and stabilized by 14-3-3 binding in solution, thereby protecting the DAPK2 inhibitory autophosphorylation site Ser318 against dephosphorylation and preventing Ca2+/CaM binding. Overall, our findings provide mechanistic insights into 14-3-3-mediated DAPK2 inhibition and highlight the potential of the DAPK2:14-3-3 complex as a target for anti-inflammatory therapies.

Department of Physical and Macromolecular Chemistry Faculty of Science Charles University Prague Czech Republic

Department of Structural Biology of Signaling Proteins Division BIOCEV Institute of Physiology of the Czech Academy of Sciences Vestec Czech Republic

Institute of Physics Faculty of Mathematics and Physics Charles University Prague Czech Republic

Zobrazit více v PubMed

Bialik S, Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu Rev. Biochem. 2006;75:189–210. doi: 10.1146/annurev.biochem.75.103004.142615. PubMed DOI

Farag AK, Roh EJ. Death-associated protein kinase (DAPK) family modulators: Current and future therapeutic outcomes. Med. Res. Rev. 2019;39:349–385. doi: 10.1002/med.21518. PubMed DOI

Shiloh R, Bialik S, Kimchi A. The DAPK family: a structure-function analysis. Apoptosis. 2014;19:286–297. doi: 10.1007/s10495-013-0924-5. PubMed DOI

Kawai T, et al. Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity. Oncogene. 1999;18:3471–3480. doi: 10.1038/sj.onc.1202701. PubMed DOI

Inbal B, Shani G, Cohen O, Kissil JL, Kimchi A. Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis. Mol. Cell Biol. 2000;20:1044–1054. doi: 10.1128/MCB.20.3.1044-1054.2000. PubMed DOI PMC

Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S. ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol. Cell Biol. 1998;18:1642–1651. doi: 10.1128/MCB.18.3.1642. PubMed DOI PMC

Sanjo H, Kawai T, Akira S. DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J. Biol. Chem. 1998;273:29066–29071. doi: 10.1074/jbc.273.44.29066. PubMed DOI

Inbal B, Bialik S, Sabanay I, Shani G, Kimchi A. DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death. J. Cell Biol. 2002;157:455–468. doi: 10.1083/jcb.200109094. PubMed DOI PMC

Geering B, et al. DAPK2 positively regulates motility of neutrophils and eosinophils in response to intermediary chemoattractants. J. Leukoc. Biol. 2014;95:293–303. doi: 10.1189/jlb.0813462. PubMed DOI

Ber Y, et al. DAPK2 is a novel regulator of mTORC1 activity and autophagy. Cell Death Differ. 2015;22:465–475. doi: 10.1038/cdd.2014.177. PubMed DOI PMC

Isshiki K, Matsuda S, Tsuji A, Yuasa K. cGMP-dependent protein kinase I promotes cell apoptosis through hyperactivation of death-associated protein kinase 2. Biochem. Biophys. Res. Commun. 2012;422:280–284. doi: 10.1016/j.bbrc.2012.04.148. PubMed DOI

Kogel D, Prehn JH, Scheidtmann KH. The DAP kinase family of pro-apoptotic proteins: novel players in the apoptotic game. Bioessays. 2001;23:352–358. doi: 10.1002/bies.1050. PubMed DOI

Patel AK, Yadav RP, Majava V, Kursula I, Kursula P. Structure of the dimeric autoinhibited conformation of DAPK2, a pro-apoptotic protein kinase. J. Mol. Biol. 2011;409:369–383. doi: 10.1016/j.jmb.2011.03.065. PubMed DOI

Simon B, et al. Death-associated protein kinase activity is regulated by coupled calcium/calmodulin binding to two distinct sites. Structure. 2016;24:851–861. doi: 10.1016/j.str.2016.03.020. PubMed DOI PMC

Kylarova S, Psenakova K, Herman P, Obsilova V, Obsil T. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert. Biochim. Biophys. Acta Gen. Subj. 2018;1862:2304–2313. doi: 10.1016/j.bbagen.2018.07.025. PubMed DOI

Matsushita M, Nairn AC. Inhibition of the Ca2+/calmodulin-dependent protein kinase I cascade by cAMP-dependent protein kinase. J. Biol. Chem. 1999;274:10086–10093. doi: 10.1074/jbc.274.15.10086. PubMed DOI

Stratton MM, Chao LH, Schulman H, Kuriyan J. Structural studies on the regulation of Ca2+/calmodulin dependent protein kinase II. Curr. Opin. Struct. Biol. 2013;23:292–301. doi: 10.1016/j.sbi.2013.04.002. PubMed DOI PMC

Britschgi A, et al. DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function. Oncogene. 2008;27:5706–5716. doi: 10.1038/onc.2008.179. PubMed DOI

Humbert M, et al. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPalpha during granulocytic differentiation but repressed by PML-RARalpha in APL. J. Leukoc. Biol. 2014;95:83–93. doi: 10.1189/jlb.1112608. PubMed DOI PMC

Li H, Ray G, Yoo BH, Erdogan M, Rosen KV. Down-regulation of death-associated protein kinase-2 is required for beta-catenin-induced anoikis resistance of malignant epithelial cells. J. Biol. Chem. 2009;284:2012–2022. doi: 10.1074/jbc.M805612200. PubMed DOI

Rizzi M, et al. The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. J. Leukoc. Biol. 2007;81:1599–1608. doi: 10.1189/jlb.0606400. PubMed DOI

Tur MK, et al. Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cells. J. Immunother. 2009;32:431–441. doi: 10.1097/CJI.0b013e31819f1cb6. PubMed DOI

Shani G, et al. Autophosphorylation restrains the apoptotic activity of DRP-1 kinase by controlling dimerization and calmodulin binding. EMBO J. 2001;20:1099–1113. doi: 10.1093/emboj/20.5.1099. PubMed DOI PMC

Shiloh R, et al. Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagy. Nat. Commun. 2018;9:1759. doi: 10.1038/s41467-018-03907-4. PubMed DOI PMC

Gilad Y, Shiloh R, Ber Y, Bialik S, Kimchi A. Discovering protein-protein interactions within the programmed cell death network using a protein-fragment complementation screen. Cell Rep. 2014;8:909–921. doi: 10.1016/j.celrep.2014.06.049. PubMed DOI

Yuasa K, et al. Suppression of death-associated protein kinase 2 by interaction with 14-3-3 proteins. Biochem. Biophys. Res. Commun. 2015;464:70–75. doi: 10.1016/j.bbrc.2015.05.105. PubMed DOI

Yaffe MB, et al. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell. 1997;91:961–971. doi: 10.1016/S0092-8674(00)80487-0. PubMed DOI

Wurtele M, Jelich-Ottmann C, Wittinghofer A, Oecking C. Structural view of a fungal toxin acting on a 14-3-3 regulatory complex. EMBO J. 2003;22:987–994. doi: 10.1093/emboj/cdg104. PubMed DOI PMC

Ganguly S, et al. Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine N-acetyltransferase mediated by phosphoserine-205. Proc. Natl Acad. Sci. USA. 2005;102:1222–1227. doi: 10.1073/pnas.0406871102. PubMed DOI PMC

Coblitz B, et al. C-terminal recognition by 14-3-3 proteins for surface expression of membrane receptors. J. Biol. Chem. 2005;280:36263–36272. doi: 10.1074/jbc.M507559200. PubMed DOI

Gogl G, et al. Hierarchized phosphotarget binding by the seven human 14-3-3 isoforms. Nat. Commun. 2021;12:1677. doi: 10.1038/s41467-021-21908-8. PubMed DOI PMC

Rose R, Rose M, Ottmann C. Identification and structural characterization of two 14-3-3 binding sites in the human peptidylarginine deiminase type VI. J. Struct. Biol. 2012;180:65–72. doi: 10.1016/j.jsb.2012.05.010. PubMed DOI

Stevers LM, et al. Characterization and small-molecule stabilization of the multisite tandem binding between 14-3-3 and the R domain of CFTR. Proc. Natl Acad. Sci. USA. 2016;113:E1152–E1161. doi: 10.1073/pnas.1516631113. PubMed DOI PMC

Anders C, et al. A semisynthetic fusicoccane stabilizes a protein-protein interaction and enhances the expression of K+ channels at the cell surface. Chem. Biol. 2013;20:583–593. doi: 10.1016/j.chembiol.2013.03.015. PubMed DOI

Simmons TJ, et al. Structural and electronic determinants of lytic polysaccharide monooxygenase reactivity on polysaccharide substrates. Nat. Commun. 2017;8:1064. doi: 10.1038/s41467-017-01247-3. PubMed DOI PMC

de Boer AH, de Vries-van Leeuwen IJ. Fusicoccanes: diterpenes with surprising biological functions. Trends Plant Sci. 2012;17:360–368. doi: 10.1016/j.tplants.2012.02.007. PubMed DOI

Molzan M, et al. Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling. Mol. Cell. Biol. 2010;30:4698–4711. doi: 10.1128/MCB.01636-09. PubMed DOI PMC

Stevers LM, et al. Modulators of 14-3-3 protein-protein interactions. J. Med. Chem. 2018;61:3755–3778. doi: 10.1021/acs.jmedchem.7b00574. PubMed DOI PMC

Saponaro A, et al. Fusicoccin activates KAT1 channels by stabilizing their interaction with 14-3-3 proteins. Plant Cell. 2017;29:2570–2580. PubMed PMC

Saline M, et al. AMPK and AKT protein kinases hierarchically phosphorylate the N-terminus of the FOXO1 transcription factor, modulating interactions with 14-3-3 proteins. J. Biol. Chem. 2019;294:13106–13116. doi: 10.1074/jbc.RA119.008649. PubMed DOI PMC

Sinz A. Cross-linking/mass spectrometry for studying protein structures and protein-protein interactions: where are we now and where should we go from here? Angew. Chem. 2018;57:6390–6396. doi: 10.1002/anie.201709559. PubMed DOI

Bernado P, Svergun DI. Structural analysis of intrinsically disordered proteins by small-angle X-ray scattering. Mol. Biosyst. 2012;8:151–167. doi: 10.1039/C1MB05275F. PubMed DOI

Tugaeva KV, Kalacheva DI, Cooley RB, Strelkov SV, Sluchanko NN. Concatenation of 14-3-3 with partner phosphoproteins as a tool to study their interaction. Sci. Rep. 2019;9:15007. doi: 10.1038/s41598-019-50941-3. PubMed DOI PMC

Psenakova K, et al. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2) Biochim. Biophys. Acta Gen. Subj. 2018;1862:1612–1625. doi: 10.1016/j.bbagen.2018.04.006. PubMed DOI

Smidova A, et al. 14-3-3 protein masks the nuclear localization sequence of caspase-2. FEBS J. 2018;285:4196–4213. doi: 10.1111/febs.14670. PubMed DOI

Receveur-Brechot V, Durand D. How random are intrinsically disordered proteins? A small angle scattering perspective. Curr. Protein Pept. Sci. 2012;13:55–75. doi: 10.2174/138920312799277901. PubMed DOI PMC

Petoukhov MV, et al. New developments in the program package for small-angle scattering data analysis. J. Appl Crystallogr. 2012;45:342–350. doi: 10.1107/S0021889812007662. PubMed DOI PMC

Shohat G, et al. The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism. J. Biol. Chem. 2001;276:47460–47467. doi: 10.1074/jbc.M105133200. PubMed DOI

Davare MA, Saneyoshi T, Guire ES, Nygaard SC, Soderling TR. Inhibition of calcium/calmodulin-dependent protein kinase kinase by protein 14-3-3. J. Biol. Chem. 2004;279:52191–52199. doi: 10.1074/jbc.M409873200. PubMed DOI

Langendorf CG, et al. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins. J. Biol. Chem. 2020;295:16239–16250. doi: 10.1074/jbc.RA120.013756. PubMed DOI PMC

Hornbeck PV, et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 2015;43:D512–D520. doi: 10.1093/nar/gku1267. PubMed DOI PMC

Park E, et al. Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes. Nature. 2019;575:545–550. doi: 10.1038/s41586-019-1660-y. PubMed DOI PMC

Sluchanko NN, et al. Structural basis for the interaction of a human small heat shock protein with the 14-3-3 universal signaling regulator. Structure. 2017;25:305–316. doi: 10.1016/j.str.2016.12.005. PubMed DOI PMC

Boston PF, Jackson P, Kynoch PA, Thompson RJ. Purification, properties, and immunohistochemical localisation of human brain 14-3-3 protein. J. Neurochem. 1982;38:1466–1474. doi: 10.1111/j.1471-4159.1982.tb07927.x. PubMed DOI

Boston PF, Jackson P, Thompson RJ. Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders. J. Neurochem. 1982;38:1475–1482. doi: 10.1111/j.1471-4159.1982.tb07928.x. PubMed DOI

Tinti M, et al. ANIA: ANnotation and Integrated Analysis of the 14-3-3 interactome. Database. 2014;2014:bat085. doi: 10.1093/database/bat085. PubMed DOI PMC

Sluchanko NN, Bustos DM. Intrinsic disorder associated with 14-3-3 proteins and their partners. Prog. Mol. Biol. Transl. Sci. 2019;166:19–61. doi: 10.1016/bs.pmbts.2019.03.007. PubMed DOI

Kostelecky B, Saurin AT, Purkiss A, Parker PJ, McDonald NQ. Recognition of an intra-chain tandem 14-3-3 binding site within PKCepsilon. EMBO Rep. 2009;10:983–989. doi: 10.1038/embor.2009.150. PubMed DOI PMC

Alblova M, et al. Molecular basis of the 14-3-3 protein-dependent activation of yeast neutral trehalase Nth1. Proc. Natl Acad. Sci. USA. 2017;114:E9811–E9820. doi: 10.1073/pnas.1714491114. PubMed DOI PMC

Kondo Y, et al. Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases. Science. 2019;366:109–115. doi: 10.1126/science.aay0543. PubMed DOI PMC

Liau NPD, et al. Negative regulation of RAF kinase activity by ATP is overcome by 14-3-3-induced dimerization. Nat. Struct. Mol. Biol. 2020;27:134–141. doi: 10.1038/s41594-019-0365-0. PubMed DOI

Obsil T, Ghirlando R, Klein DC, Ganguly S, Dyda F. Crystal structure of the 14-3-3zeta:serotonin N-acetyltransferase complex. a role for scaffolding in enzyme regulation. Cell. 2001;105:257–267. doi: 10.1016/S0092-8674(01)00316-6. PubMed DOI

Johannessen CM, et al. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature. 2010;468:968–972. doi: 10.1038/nature09627. PubMed DOI PMC

Holakovska B, Grycova L, Bily J, Teisinger J. Characterization of calmodulin binding domains in TRPV2 and TRPV5 C-tails. Amino Acids. 2011;40:741–748. doi: 10.1007/s00726-010-0712-2. PubMed DOI

Petrvalska O, et al. Structural insight into the 14-3-3 protein-dependent inhibition of protein kinase ASK1 (apoptosis signal-regulating kinase 1) J. Biol. Chem. 2016;291:20753–20765. doi: 10.1074/jbc.M116.724310. PubMed DOI PMC

Panjkovich A, Svergun DI. CHROMIXS: automatic and interactive analysis of chromatography-coupled small-angle X-ray scattering data. Bioinformatics. 2018;34:1944–1946. doi: 10.1093/bioinformatics/btx846. PubMed DOI PMC

Svergun DI. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 1992;25:495–503. doi: 10.1107/S0021889892001663. DOI

Konarev PV, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI. PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 2003;36:1277–1282. doi: 10.1107/S0021889803012779. DOI

Franke D, Svergun DI. DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. J. Appl. Crystallogr. 2009;42:342–346. doi: 10.1107/S0021889809000338. PubMed DOI PMC

Volkov VV, Svergun DI. Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Crystallogr. 2003;36:860–864. doi: 10.1107/S0021889803000268. PubMed DOI PMC

Kozin MB, Svergun DI. Automated matching of high- and low-resolution structural models. J. Appl. Crystallogr. 2001;34:33–41. doi: 10.1107/S0021889800014126. DOI

Niesen FH, Berglund H, Vedadi M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat. Protoc. 2007;2:2212–2221. doi: 10.1038/nprot.2007.321. PubMed DOI

Kabsch W. Xds. Acta Crystallogr. D Biol. Crystallogr. 2010;66:125–132. doi: 10.1107/S0907444909047337. PubMed DOI PMC

Vagin A, Teplyakov A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 1997;30:1022–1025. doi: 10.1107/S0021889897006766. DOI

Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. PubMed DOI PMC

Kincaid RL, Vaughan M, Osborne JC, Jr., Tkachuk VA. Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I. J. Biol. Chem. 1982;257:10638–10643. doi: 10.1016/S0021-9258(18)33870-5. PubMed DOI

Vecer J, Herman P. Maximum entropy analysis of analytically simulated complex fluorescence decays. J. Fluorescence. 2011;21:873–881. doi: 10.1007/s10895-009-0589-1. PubMed DOI

Bryan RK. Maximum-entropy analysis of oversampled data problems. Eur. Biophys. J. 1990;18:165–174. doi: 10.1007/BF02427376. DOI

Look for the Scaffold: Multifaceted Regulation of Enzyme Activity by 14-3-3 Proteins

The yeast 14-3-3 proteins Bmh1 and Bmh2 regulate key signaling pathways

14-3-3 protein inhibits CaMKK1 by blocking the kinase active site with its last two C-terminal helices

Molecular basis and dual ligand regulation of tetrameric estrogen receptor α/14-3-3ζ protein complex

Structural insights into the functional roles of 14-3-3 proteins

Structural basis for SARS-CoV-2 nucleocapsid (N) protein recognition by 14-3-3 proteins

Nedd4-2 binding to 14-3-3 modulates the accessibility of its catalytic site and WW domains